This message was sent to ##Email##
|
|
|
|
|
The Washington Post
Vice President Biden will convene a daylong cancer summit in Washington on June 29 that will be part pep rally, part Ted talk, part wonk-a-thon — all designed to garner support for the Obama administration's yearlong initiative to advance cancer research.
The summit, which is expected to draw as many as 300 people from academia, industry and advocacy groups to Howard University, is billed as a way to generate new ideas to beat a disease that kills almost 600,000 Americans a year.
READ MORE
OncLive
The FDA has granted nivolumab (Opdivo) a breakthrough therapy designation for the treatment of patients with unresectable locally advanced or metastatic urothelial carcinoma (mUC) after the failure of a platinum-containing regimen, according to Bristol-Myers Squibb, the manufacturer of the PD-1 inhibitor.
READ MORE
|
Promoted by
|
|
|
|
 |
News-Medical.Net
In a study of older women with newly diagnosed stage I to III breast cancer, approximately one in five lost the ability to complete some of the basic tasks necessary for independent living within one year of initiating treatment. The study also found that a simple survey can help identify which women are at risk of such functional decline. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
READ MORE
AJCC
The AJCC announces five disease site webinars that are scheduled for summer and early fall this year. The webinars, provided at no cost, will provide highlights of the five most common site chapters for AJCC 7th edition staging and include: Melanoma, Lung, Breast, Colorectum and Prostate. There will be pre- and post-education quizzes to serve as a self-assessment for the information learned. The webinars will provide information on the uniqueness, differences, exceptions or special concerns for the disease sites.
Each lecture will contain the following topics:
Overview and Learning Objectives
Anatomy Affecting Stage
Classification Issues
Assigning T, N, M, Stage Group
Information and Questions on AJCC Staging and Summary
The first live webinar (Melanoma) will occur on July 27. Register now. This webinar will be recorded for anyone who is not able to attend the live session.
You can visit the AJCC website to learn more about the Disease Site webinars and stay informed.
| |
PRODUCT SHOWCASE | Advertisement
|
 |
|
Enjoy our journals? There’s an app for those! Journals such as those from the American Cancer Society ™, Journal of Surgical Oncology, Cancer Science and more are now available for your iPad and iPhone. Sample issues and abstracts, as well as open articles, can be accessed for free. A subscription to the journal is required to read the full text.
|
|
CNN
Fewer than half of ovarian cancer patients survive more than five years after their diagnosis. But new research indicates that preemptive surgery to remove a woman's ovaries and fallopian tubes might benefit more women than previously thought.
According to a recent study by Queen Mary University London scientists, for women age 40 or older with a lifetime risk level of 4 percent or greater, this operation, in combination with hormone replacement therapy, would provide 43 extra days of life expectancy on average.
READ MORE
ACS
The American College of Surgeons is seeking eight Fellows to fill vacancies on the Commission on Cancer (CoC). The initial term of appointment is three years with eligibility for reelection to a second term. Members may hold office or serve as vice-chair of a committee or subcommittee during their second term. New members will be recommended by the Nominating Committee, selected in October by the Executive Committee, and then brought before the full CoC membership for approval at the CoC's Annual Meeting. The ACS Board of Regents will confirm the final list of new members, and the CoC will announce the new members in late October.
READ MORE
| |
SPONSORED CONTENT | Advertisement
|
|
Promoted by
|
|
|
|
 |
The Associated Press via The Wall Street Journal
New York state is expanding access to breast-cancer screening by requiring hospitals to extend hours for mammograms and eliminating insurance costs.
Under the new law, which Democratic Gov. Andrew Cuomo signed recently, more than 200 hospitals around the state will be required to offer evening and weekend hours for mammograms. Insurance companies will be prohibited from charging deductibles or copays for the procedure.
READ MORE
Oncology Nurse Advisor
Aspirin use apparently offers protection against bile duct cancer, according to the findings of a recently published study. Bile duct cancer, or cholangiocarcinoma, is a particularly aggressive and lethal cancer that has been increasing in incidence in the United States.
READ MORE
|
|
Advertisement
 |
|
For the past 22 years, EduCare's mission has been to support Healthcare Professionals in educating breast cancer patients. We strive to offer products that are patient-friendly and up-to-date. Patient education increases compliance, reduces time constraints and promotes a partnership between patient and healthcare providers.
|
|
|
|
|
Advertisement
 |
|
Specialty Practice Management is a complete front- and back-office solution that offers a rapid return on your investment and improved satisfaction among your staff. Practices with 10 or fewer providers turn to this comprehensive solution to manage self-pay accounts and eliminate common mistakes.
|
|
|
|
Reuters
Families may be happiest with end-of-life care when their loved ones have cancer or dementia, because those patients are often treated with a focus on comfort and quality of life as they reach their final days, a U.S. study finds.
At 146 Veteran Affairs facilities nationwide, researchers surveyed family members of more than 34,000 patients who died of cancer, kidney failure, cardiopulmonary failure, dementia or frailty.
READ MORE
Cure
As advances continue to be made for the treatment of a variety of sarcomas, researchers are still working to improve outcomes for pediatric, adolescent and young adult patients — a prevalent population with the disease.
READ MORE
Medical Xpress
A new U.K. study has identified a gene signature that predicts poor survival from ovarian cancer. The study also identified genes that help the cancer develop resistance to chemotherapy — offering a new route to help tackle the disease.
READ MORE
OncLive
The EMA's Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for use of pembrolizumab (Keytruda) as a treatment for patients with locally advanced or metastatic PD-L1-positive non–small cell lung cancer (NSCLC) following at least one chemotherapy regimen.
READ MORE
For additional information, please complete the mailing list request form.
|
|
|
Advertisement
Advertisement
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
